Exploring CAR cell therapies beyond CAR-T for myeloid malignancies
Abstract Chimeric antigen receptor (CAR)-T cells have demonstrated remarkable efficacy in several hematologic malignancies; however, their application in myeloid malignancies such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) remains limited, with no FDA-approved products to da...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2026-06-01
|
| Серія: | Journal of Biomedical Science |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12929-026-01265-8 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|